These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
3. Oral medications for minimal brain dysfunction in children. Green RP; Scales SM; Rosser PL J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677 [No Abstract] [Full Text] [Related]
4. MBD: advanced in understanding many bothersome dilemmas. Seals JR Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279 [No Abstract] [Full Text] [Related]
5. The neurological evaluation of children with learning disorders. Schain RJ Calif Med; 1973 Jun; 118(6):24-32. PubMed ID: 4709522 [No Abstract] [Full Text] [Related]
6. A long-term comparison of two treatment regimens for minimal brain dysfunction. Drug therapy versus combined therapy. Friedman R; Dale EP; Wagner JH Clin Pediatr (Phila); 1973 Nov; 12(11):666-71. PubMed ID: 4759509 [No Abstract] [Full Text] [Related]
7. Mood-altering drugs and hyperkinetic children. Erenberg G Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542 [No Abstract] [Full Text] [Related]
8. Amphetamine-type drugs for hyperactive children. Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553 [No Abstract] [Full Text] [Related]
10. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction. Gross MD Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966 [TBL] [Abstract][Full Text] [Related]
11. [The minimal brain dysfunction syndrome]. Verret S Vie Med Can Fr; 1973 Jul; 2(7):649-55. PubMed ID: 4760948 [No Abstract] [Full Text] [Related]
12. Minimal brain dysfunction and methylphenidate. Schwartz ML; Pizzo SV; McKee PA N Engl J Med; 1971 Jul; 285(5):293. PubMed ID: 5090403 [No Abstract] [Full Text] [Related]
13. Evaluating and managing attention deficit disorder in children who are deaf or hard of hearing. Kelly D; Forney J; Parker-Fisher S; Jones M Am Ann Deaf; 1993 Oct; 138(4):349-57. PubMed ID: 8273706 [TBL] [Abstract][Full Text] [Related]
15. Drugs in management of hyperkinetic and perceptually handicapped children. Millichap JG JAMA; 1968 Nov; 206(7):1527-30. PubMed ID: 4386794 [No Abstract] [Full Text] [Related]
16. Minimal brain dysfunction in children. Diagnosis and management. Wender PH Pediatr Clin North Am; 1973 Feb; 20(1):187-202. PubMed ID: 4581984 [No Abstract] [Full Text] [Related]
17. Drug therapy in minimal brain dysfunction: a commentary. Erenberg G J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602 [No Abstract] [Full Text] [Related]
18. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children. Eisenberg L Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174 [No Abstract] [Full Text] [Related]
19. The what, why and how of hyperkinesis: implications for nursing. Porter LS J Adv Nurs; 1988 Mar; 13(2):229-36. PubMed ID: 3286714 [TBL] [Abstract][Full Text] [Related]
20. Acceptable and controversial approaches to treating the child with learning disabilities. Silver LB Pediatrics; 1975 Mar; 55(3):406-15. PubMed ID: 238179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]